Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

352 ARTÍCULOS , VIENDO DEL 316 AL 330

Blood-based biomarkers for detecting Alzheimer's disease pathology in cognitively impaired individuals within specialized care settings: A systematic review and meta-analysis

Pahlke S, Kahale LA, Mahinrad S, Sousa-Pinto B, Vieira RJ, McAteer MB, Claessen T, Contador J, Hofmann A, Kuchenbecker LA, Machado LS, Warmenhoven N, Yakoub Y, Palmqvist S, Schindler SE, Teunissen C, Whitson HE, Zetterberg H, Edelmayer R, Tampi MP.

Alzheimers Dement. 2025 Nov;21(11):e70828. doi: 10.1002/alz.70828.

Associations among sleep quality, sleep duration, and Alzheimer's disease biomarkers: A systematic review and meta-analysis

Chen CL, Zhang MY, Wang ZL, Deng JH, Bao YP, Shi J, Lu L, Shi L.

Alzheimers Dement. 2025 Mar;21(3):e70096. doi: 10.1002/alz.70096.

Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ 2 Randomized Clinical Trial

Lu M, Kim MJ, Collins EC, Shcherbinin S, Ellinwood AK, Yokoi Y, Brooks DA, Hansson O, Knopman DS, Sims JR, Mintun MA.

JAMA Neurol. 2025 Dec 1;82(12):1251-1256. doi: 10.1001/jamaneurol.2025.3869.

Proteomic landscape of Alzheimer's disease: emerging technologies, advances and insights (2021 - 2025)

Yarbro JM, Shrestha HK, Wang Z, Zhang X, Zaman M, Chu M, Wang X, Yu G, Peng J.

Mol Neurodegener. 2025 Jul 14;20(1):83. doi: 10.1186/s13024-025-00874-5.

Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease

Salvadó G, Janelidze S, Bali D, Dolado AO, Therriault J, Brum WS, Pichet Binette A, Stomrud E, Mattsson-Carlgren N, Palmqvist S, Coomans EM, Teunissen CE, van der Flier WM, Rahmouni N, Benzinger TLS, Gispert JD, Blennow K, Doré V, Feizpour A, Rowe CC, Alcolea D, Fortea J, Villeneuve S, Johnson SC, Rosa-Neto P, Petersen RC, Jack CR Jr, Schindler SE, Suárez-Calvet M, Ossenkoppele R, Hansson O; ADNI, ALFA, and PREVENT-AD Study Groups.

JAMA Neurol. 2025 Nov 1;82(11):1122-1134. doi: 10.1001/jamaneurol.2025.3217.

Alzheimer Disease Blood Biomarkers and Cognition Among Individuals With Diabetes and Overweight or Obesity

Mielke MM, Evans JK, Neiberg RH, Molina-Henry DP, Marcovina SM, Johnson KC, Carmichael OT, Rapp SR, Sachs BC, Ding J, Shappell HM, Luchsinger JA, Espeland MA, Hayden KM.

JAMA Netw Open. 2025 Feb 3;8(2):e2458149. doi: 10.1001/jamanetworkopen.2024.58149.

Cognitive Phenotyping and Interpretation of Alzheimer Blood Biomarkers

Bouteloup V, Villain N, Vidal JS, Gonzalez-Ortiz F, Yuksekel I, Santos C, Schraen-Maschken S, Pellegrin I, Lehmann S, Blennow K, Chêne G, Hanon O, Dufouil C, Planche V; MEMENTO and the BALTAZAR Study Groups.

JAMA Neurol. 2025 May 1;82(5):506-515. doi: 10.1001/jamaneurol.2025.0142.

Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease

Leuzy A, Bollack A, Pellegrino D, Teunissen CE, La Joie R, Rabinovici GD, Franzmeier N, Johnson K, Barkhof F, Shaw LM, Arkhipenko A, Schindler SE, Honig LS, Moscoso Rial A, Schöll M, Zetterberg H, Blennow K, Hansson O, Farrar G.

Alzheimers Dement. 2025 Mar;21(3):e14528. doi: 10.1002/alz.14528.

Plasma p-tau immunoassays in clinical research for Alzheimer's disease

Teunissen CE, Kolster R, Triana-Baltzer G, Janelidze S, Zetterberg H, Kolb HC.

Alzheimers Dement. 2025 Jan;21(1):e14397. doi: 10.1002/alz.14397. Epub 2024 Dec 3.

Lecanemab for early Alzheimer's disease: Appropriate use recommendations from the French federation of memory clinics

Villain N, Planche V, Lilamand M, Cordonnier C, Soto-Martin M, Mollion H, Bombois S, Delrieu J; French Federation of Memory Clinics Work Group on Anti-Amyloid Immunotherapies.

J Prev Alzheimers Dis. 2025 Apr;12(4):100094. doi: 10.1016/j.tjpad.2025.100094. Epub 2025 Feb 25.

Neuroinflammatory fluid biomarkers in patients with Alzheimer's disease: a systematic literature review

Heneka MT, Gauthier S, Chandekar SA, Hviid Hahn-Pedersen J, Bentsen MA, Zetterberg H.

Mol Psychiatry. 2025 Jun;30(6):2783-2798. doi: 10.1038/s41380-025-02939-9. Epub 2025 Mar 6.

Down syndrome and Alzheimer's disease: insights into biomarkers, clinical symptoms, and pathology

Rafii MS, Schlachetzki Z, Barroeta I, Head E, Fortea J, Ances BM.

Lancet Neurol. 2025 Sep;24(9):753-762. doi: 10.1016/S1474-4422(25)00237-6.

Effects of exercise on cognition and Alzheimer's biomarkers in a randomized controlled trial of adults with mild cognitive impairment: The EXERT study

Baker LD, Pa JA, Katula JA, Aslanyan V, Salmon DP, Jacobs DM, Chmelo EA, Hodge H, Morrison R, Matthews G, Brewer J, Jung Y, Rissman RA, Taylor C, Léger GC, Messer K, Evans AC, Okonkwo OC, Shadyab AH, Zou J, Jin S, Thomas RG, Zhang J, La Croix AZ, Cotman CW, Feldman HH; EXERT Study Group.

Alzheimers Dement. 2025 Apr;21(4):e14586. doi: 10.1002/alz.14586.

Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer's disease pathology among cognitively impaired and unimpaired: A systematic review and meta-analysis

Khalafi M, Dartora WJ, McIntire LBJ, Butler TA, Wartchow KM, Hojjati SH, Razlighi QR, Shirbandi K, Zhou L, Chen K, Xi K, Banerjee S, Foldi N, Pahlajani S, Glodzik L, Li Y, de Leon MJ, Chiang GC.

Alzheimers Dement. 2025 Feb;21(2):e14458. doi: 10.1002/alz.14458. Epub 2024 Dec 23.

Blood phosphorylated tau for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

Therriault J, Brum WS, Trudel L, Macedo AC, Bitencourt FV, Martins-Pfeifer CC, Nakouzi M, Pola I, Wong M, Kac PR, Real AP, Witherow C, Karikari TK, Moscoso A, Zimmer ER, Schöll M, Pascoal T, Benedet AL, Ashton NJ, Schindler SE, Zetterberg H, Blennow K, Rosa-Neto P.

Lancet Neurol. 2025 Sep;24(9):740-752. doi: 10.1016/S1474-4422(25)00227-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias